Keloid. Hypertrophic scar
Conditions
Interventions
Intervention group: Every two weeks for 3 months, using a fine 50cc insulin syringe head, first needling was performed on the keloid lesions (lesions anywhere on the body except the face and genital a
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: Individuals with a clinical diagnosis of primary keloid by a dermatological specialist 15 years of age and older who volunteer to participate in this research Individuals who have not received any treatment for keloid lesions and in case of previous treatment, at least 3 months from Colloidal lesions on the trunk, limbs, back and hips
Exclusion criteria
Exclusion criteria: The presence of skin disease around the selected keloid lesion for treatment, such as various types of dermatitis and infectious and fungal diseases Pregnancy Breastfeeding Colloidal lesions on the face and genitals History of recent scar treatment (less than 3 months have passed since his treatment) Background of previous drug sensitivity to NSAIDs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Keloid score in POSAS questionnair. Timepoint: At the beginning of the study and 3 months after the start of the study. Method of measurement: The patient and observer Scar Assessment scale/Dermoscopy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactVahid Mashayekhiquyonlu
Mashhad University of Medical Sciences
Outcome results
None listed